Oligoadenylate synthetase 1 displays dual antiviral mechanisms in driving translational shutdown and protecting

Munesh K Harioudh1, Joseph Perez1, Zhenlu Chong2

  • 1Cancer Virology Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Department of Microbiology and Molecular Genetics, Pittsburgh, PA, USA.

Immunity
|February 29, 2024
PubMed

Insights

Oligoadenylate synthetase 1 (OAS1) has dual antiviral roles. It inhibits SARS-CoV-2 via RNase L but protects interferon expression from shutdown for other viruses.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Cellular responses to viral infection involve balancing translational control and antiviral component induction, such as interferons (IFNs).
  • The specific roles of distinct oligoadenylate synthetase 1 (OAS1) isoforms in antiviral defense are not fully understood.
  • Understanding these mechanisms is crucial for developing broad-spectrum antiviral strategies.

Purpose of the Study:

  • To investigate the distinct antiviral mechanisms of human and mouse OAS1 against different viruses.
  • To elucidate the role of OAS1 isoforms in regulating viral replication and interferon production.
  • To identify the molecular interactions of OAS1 with viral components and host cell machinery.

Main Methods:

  • Comparative analysis of OAS1 function in human and mouse cells infected with SARS-CoV-2 and West Nile virus.
  • Enzyme activity assays to assess canonical RNase L activation by OAS1.
  • RNA immunoprecipitation and mRNA stability assays to study OAS1 binding to AU-rich elements (AREs) and IFNβ mRNA localization.

Main Results:

  • Human OAS1 inhibits SARS-CoV-2 replication through canonical RNase L activity, while mouse OAS1 does not.
  • Both human and mouse OAS1 protect against West Nile virus via a non-canonical mechanism independent of RNase L.
  • OAS1 binds to AU-rich elements (AREs) on IFNβ mRNA, sequestering it to endomembranes, prolonging its half-life and translation.

Conclusions:

  • OAS1 exhibits dual antiviral functions: inhibiting viral replication and promoting interferon expression.
  • The canonical RNase L-dependent pathway is specific to human OAS1 against SARS-CoV-2.
  • OAS1 acts as an ARE-binding protein, providing a non-canonical antiviral mechanism by stabilizing IFNβ mRNA against translational shutdown.

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
781
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.0K